According to Verastem Oncology 's latest financial reports the company's current EPS (TTM) is -$6.22. In 2022 the company made an earnings per share (EPS) of -$6.45 an increase over its 2021 EPS that were of -$7.00.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.89 | -8.61% |
2022 | -$6.45 | -7.93% |
2021 | -$7.00 | -22.64% |
2020 | -$9.05 | -73.63% |
2019 | -$34.33 | 77.88% |
2018 | -$19.30 | -35.43% |
2017 | -$29.89 | 78.57% |
2016 | -$16.74 | -39.51% |
2015 | -$27.67 | -21.74% |
2014 | -$35.36 | 13.74% |
2013 | -$31.09 | 7.06% |
2012 | -$29.04 | -73.3% |
2011 | -$108.76 |